Compositions and methods for the specific inhibition of gene expression by dsRNA possessing modifications

Details for Australian Patent Application No. 2009293636 (hide)

Owner Dicerna Pharmaceuticals, Inc.

Inventors Brown, Bob

Agent Wrays

Pub. Number AU-A-2009293636

PCT Pub. Number WO2010/033225

Priority 61/136,741 22.09.08 US; 61/136,736 22.09.08 US

Filing date 17 September 2009

Wipo publication date 25 March 2010

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

21 April 2011 PCT application entered the National Phase

  PCT publication WO2010/033225 Priority application(s): WO2010/033225

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009293640-Methods and vectors for display of 2G12 -derived domain exchanged antibodies

2009293629-Method and system for providing targeted and individualized delivery of cosmetic actives